Procedures & recovery · patient guide

Fertility preservation before cancer treatment in China: questions patients ask

Fertility preservation before cancer treatment means discussing egg, embryo or sperm freezing with your oncology and fertility teams before gonadotoxic therapy begins. In China, availability, urgency and legal requirements depend on the hospital and your situation. The first practical step is asking your cancer team whether treatment can safely wait for a fertility consultation, and what they need from it.

Go to the practical guidance ↓
AI illustration: A female doctor in a white coat consulting with a female patient at a round table in a bright room with plants.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

Why the oncology team sets the clock, not the fertility clinic alone

Cancer treatment decisions and fertility decisions are linked by timing. Some chemotherapy regimens, pelvic radiotherapy and certain surgeries can reduce fertility, but the degree depends on the drugs, doses, field and the person. That is why the question is not simply whether fertility preservation is possible, but whether it can be completed without compromising cancer treatment that is already planned.

Ask your treating oncologist directly: does this regimen carry a meaningful risk to fertility, and is there a window before it starts in which a fertility consultation could take place? The oncologist also needs to say whether delaying treatment for stimulation or a procedure is acceptable in your case. No coordinator, and no article, can answer that for you.

A useful way to frame the conversation is to ask for the answer in writing where possible: the planned regimen, the intended start date, and any stated concerns about delay. The fertility service can then assess whether a preservation route fits that window. If the cancer team says treatment cannot wait, that answer takes priority over any preservation plan.

Which preservation options might be discussed

For people with ovaries, the main routes discussed are embryo cryopreservation, mature oocyte cryopreservation after controlled ovarian stimulation, and, in selected situations, ovarian tissue cryopreservation. Each has different requirements. Stimulation takes days and involves hormone medication and monitoring; the number of mature eggs retrieved varies with age and ovarian reserve. Embryo freezing requires sperm, either from a partner or a donor, depending on what the clinic permits and what the patient chooses.

For people with testes, sperm cryopreservation is the established option and is often arranged quickly when semen can be produced. If that is not possible, clinicians may discuss testicular sperm extraction, which is a procedure with its own risks and success uncertainties. For adolescents and children, options are more limited and are handled by specialist teams; the discussion is different from adult fertility preservation.

These are general categories, not a menu that applies to everyone. Your cancer type, the urgency of treatment, your age, ovarian reserve, prior fertility history and any legal or ethical requirements at the hospital all shape what is offered. Ask the fertility clinician to explain which options are realistic for you, what each involves, and what is known and unknown about the chance of a future pregnancy from each route.

What the fertility consultation needs from your cancer records

A fertility clinician assessing you before cancer treatment needs enough oncology information to judge timing and safety. That generally includes the cancer diagnosis and stage, the proposed treatment plan with drug names and planned start date, relevant imaging and pathology reports, and any prior surgery or treatment. It also helps to bring your fertility history, menstrual history where relevant, and any previous fertility testing.

You do not need to assemble a complete archive before an initial conversation. A brief summary of the diagnosis, the planned treatment and the urgency is enough to start. After first contact, the team can tell you which documents are actually needed and how to share them securely. Ask specifically whether the hospital wants records translated, and whether it accepts copies or requires originals.

One question worth asking early is who at the cancer hospital will communicate with the fertility service. In a time-sensitive situation, a named contact on each side reduces the chance that a request sits unanswered. Ask whether the fertility clinic needs a referral letter from the oncologist, and whether the oncologist needs to confirm in writing that a short delay is acceptable.

When the cancer diagnosis is already urgent

Sometimes the honest answer is that there is no realistic window. If the oncology team judges that treatment must start immediately, fertility preservation may not be feasible, and the conversation shifts to what can be done later, including referral to a fertility service after treatment and discussion of long-term options. That is a clinical decision for the treating team, and it should be documented.

If you are already mid-treatment, the question changes. Some preservation routes are not appropriate during certain phases of treatment, and the fertility clinician will need to know exactly what you have received and when. Ask whether any option remains, and what the evidence and risks are for your situation. Do not stop or delay cancer treatment on the basis of general information; speak to your treating oncologist first.

For patients travelling to China, urgency also raises practical questions: how quickly a consultation can be arranged, whether the hospital can see you at short notice, and whether the oncology and fertility teams can coordinate across departments. These are questions to put to the specific hospital, not assumptions to make from a website.

A practical next step

Start with your cancer team. Ask whether your planned treatment affects fertility, whether a delay for fertility preservation is acceptable, and how much time is available. Then ask the fertility service which options fit that window and what records they need. Keep the two conversations connected, because a preservation plan that the oncology team has not agreed to is not a plan.

If you are considering care in China, a short initial enquiry describing the diagnosis, the planned cancer treatment and your main fertility question is enough to begin. The team can identify missing information and suggest the relevant next step. This is not a diagnosis, a clinical opinion or a promise that a hospital will accept you or that a particular option is available. Hospital acceptance and clinical suitability are decided by the treating hospital and licensed clinicians.

Bring your questions in writing, ask for answers in writing where you can, and confirm the scope of any quoted service before committing. Fertility preservation is time-sensitive, but it is also a decision that belongs with your oncology and fertility clinicians, who can weigh the risks and alternatives for your individual situation.

Cancer care in China for international patients

Sources & scope of this guide

References and official service information relevant to this guide.

  1. radiotherapy
  2. payment
  3. Cancer care in China for international patients

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.